![Noreen Henig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noreen Henig
Directeur/Membre du Conseil chez
Lazard Healthcare Acquisition Corp. I
Profil
Noreen Roth Henig is currently an Independent Director at Lazard Healthcare Acquisition Corp.
I.
Former positions include Independent Director at Avidity Biosciences, Inc. (2019–2026), Independent Director at Lazard Growth Acquisition Corp.
I (2021–2023), Chief Medical Officer at Kezar Life Sciences, Inc. (2020–2023), Chief Medical Officer at Breath Therapeutics GmbH (2018–2020), Chief Development Officer at ProQR Therapeutics NV (2014–2017), Senior Director-Global Respiratory at Gilead Sciences, Inc. (2011–2014), and Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation (1999–2008).
Education includes an undergraduate degree from Yale University (1987) and a doctorate from Albert Einstein College of Medicine, Inc. (1991).
Postes actifs de Noreen Henig
| Sociétés | Poste | Début |
|---|---|---|
Lazard Healthcare Acquisition Corp. I
 Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Anciens postes connus de Noreen Henig
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur/Membre du Conseil | 27/02/2026 |
| KEZAR LIFE SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 06/10/2023 |
| LAZARD GROWTH ACQUISITION CORP. I | Directeur/Membre du Conseil | 01/02/2023 |
Breath Therapeutics GmbH
 Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Directeur Technique/Scientifique/R&D | 01/03/2020 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/11/2017 |
Formation de Noreen Henig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Commercial Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Health Technology |
Lazard Growth Acquisition Corp. I
 Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Operates as a blank check company | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
